Northern Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.4M | Buy |
257,389
+3,231
| +1% | +$761K | 0.01% | 915 |
|
|
2026
Q1 | $50.7M | Buy |
254,158
+3,518
| +1% | +$696K | 0.01% | 1086 |
|
|
2025
Q4 | $47.4M | Sell |
250,640
-15,322
| -6% | -$2.94M | 0.01% | 1144 |
|
|
2025
Q3 | $47.1M | Sell |
265,962
-10,819
| -4% | -$1.61M | 0.01% | 1175 |
|
|
2025
Q2 | $31.5M | Sell |
276,781
-17,027
| -6% | -$1.82M | ﹤0.01% | 1382 |
|
|
2025
Q1 | $30.9M | Buy |
293,808
+10,851
| +4% | +$1.23M | ﹤0.01% | 1369 |
|
|
2024
Q4 | $30.3M | Buy |
282,957
+20,207
| +8% | +$2.28M | ﹤0.01% | 1438 |
|
|
2024
Q3 | $26.3M | Buy |
262,750
+57,847
| +28% | +$5.82M | ﹤0.01% | 1453 |
|
|
2024
Q2 | $17.3M | Sell |
204,903
-5,383
| -3% | -$428K | ﹤0.01% | 1649 |
|
|
2024
Q1 | $15.4M | Sell |
210,286
-9,494
| -4% | -$700K | ﹤0.01% | 1775 |
|
|
2023
Q4 | $15.7M | Sell |
219,780
-101
| -0% | -$5.96K | ﹤0.01% | 1787 |
|
|
2023
Q3 | $13.2M | Buy |
219,881
+1,576
| +0.7% | +$104K | ﹤0.01% | 1817 |
|
|
2023
Q2 | $15.7M | Buy |
218,305
+15,714
| +8% | +$1.18M | ﹤0.01% | 1750 |
|
|
2023
Q1 | $14.9M | Sell |
202,591
-686
| -0.3% | -$48.8K | ﹤0.01% | 1748 |
|
|
2022
Q4 | $13.6M | Sell |
203,277
-74,223
| -27% | -$4.83M | ﹤0.01% | 1800 |
|
|
2022
Q3 | $14.9M | Sell |
277,500
-38,645
| -12% | -$2.27M | ﹤0.01% | 1697 |
|
|
2022
Q2 | $17.6M | Sell |
316,145
-8,004
| -2% | -$454K | ﹤0.01% | 1617 |
|
|
2022
Q1 | $22.7M | Sell |
324,149
-54,646
| -14% | -$3.96M | ﹤0.01% | 1581 |
|
|
2021
Q4 | $36.5M | Sell |
378,795
-3,985
| -1% | -$368K | 0.01% | 1337 |
|
|
2021
Q3 | $33.3M | Sell |
382,780
-74,885
| -16% | -$5.79M | 0.01% | 1400 |
|
|
2021
Q2 | $37.5M | Buy |
457,665
+80,872
| +21% | +$6.73M | 0.01% | 1383 |
|
|
2021
Q1 | $35.8M | Sell |
376,793
-12,667
| -3% | -$1.2M | 0.01% | 1393 |
|
|
2020
Q4 | $24.2M | Sell |
389,460
-39,107
| -9% | -$2.23M | ﹤0.01% | 1664 |
|
|
2020
Q3 | $25.5M | Sell |
428,567
-48,890
| -10% | -$3.34M | 0.01% | 1439 |
|
|
2020
Q2 | $33.3M | Buy |
477,457
+1,829
| +0.4% | +$116K | 0.01% | 1211 |
|
|
2020
Q1 | $21.6M | Sell |
475,628
-11,623
| -2% | -$659K | 0.01% | 1339 |
|
|
2019
Q4 | $31.7M | Sell |
487,251
-47,455
| -9% | -$3.17M | 0.01% | 1362 |
|
|
2019
Q3 | $33.2M | Sell |
534,706
-31,858
| -6% | -$2M | 0.01% | 1283 |
|
|
2019
Q2 | $40.3M | Sell |
566,564
-35,430
| -6% | -$2.61M | 0.01% | 1168 |
|
|
2019
Q1 | $47.2M | Buy |
601,994
+17,842
| +3% | +$1.35M | 0.01% | 1002 |
|
|
2018
Q4 | $49.5M | Buy |
584,152
+81,644
| +16% | +$8.7M | 0.01% | 861 |
|
|
2018
Q3 | $86M | Buy |
502,508
+3,739
| +0.7% | +$564K | 0.02% | 632 |
|
|
2018
Q2 | $64.5M | Buy |
498,769
+3,144
| +0.6% | +$351K | 0.02% | 798 |
|
|
2018
Q1 | $51.1M | Sell |
495,625
-3,844
| -0.8% | -$380K | 0.01% | 983 |
|
|
2017
Q4 | $42.7M | Sell |
499,469
-5,369
| -1% | -$465K | 0.01% | 1103 |
|
|
2017
Q3 | $42.9M | Sell |
504,838
-2,651
| -0.5% | -$210K | 0.01% | 1074 |
|
|
2017
Q2 | $38.4M | Buy |
507,489
+35,237
| +7% | +$2.46M | 0.01% | 1141 |
|
|
2017
Q1 | $31.2M | Buy |
472,252
+2,347
| +0.5% | +$154K | 0.01% | 1309 |
|
|
2016
Q4 | $29.8M | Sell |
469,905
-226,368
| -33% | -$14.3M | 0.01% | 1285 |
|
|
2016
Q3 | $44.3M | Buy |
696,273
+30,473
| +5% | +$2.24M | 0.01% | 937 |
|
|
2016
Q2 | $49.5M | Sell |
665,800
-12,572
| -2% | -$933K | 0.02% | 815 |
|
|
2016
Q1 | $42M | Sell |
678,372
-29,226
| -4% | -$1.78M | 0.01% | 921 |
|
|
2015
Q4 | $47.9M | Buy |
707,598
+36,693
| +5% | +$2.27M | 0.02% | 829 |
|
|
2015
Q3 | $35.8M | Sell |
670,905
-53,596
| -7% | -$3.25M | 0.01% | 1029 |
|
|
2015
Q2 | $45.6M | Buy |
724,501
+34,158
| +5% | +$1.86M | 0.01% | 928 |
|
|
2015
Q1 | $33.2M | Buy |
690,343
+17,798
| +3% | +$682K | 0.01% | 1181 |
|
|
2014
Q4 | $22.3M | Buy |
672,545
+8,597
| +1% | +$280K | 0.01% | 1453 |
|
|
2014
Q3 | $19.5M | Buy |
663,948
+261,885
| +65% | +$8.69M | 0.01% | 1530 |
|
|
2014
Q2 | $15.6M | Sell |
402,063
-188,945
| -32% | -$7.67M | ﹤0.01% | 1720 |
|
|
2014
Q1 | $24.8M | Buy |
591,008
+125,904
| +27% | +$5.25M | 0.01% | 1388 |
|
|
2013
Q4 | $15.3M | Buy |
465,104
+8,663
| +2% | +$282K | ﹤0.01% | 1761 |
|
|
2013
Q3 | $12.3M | Sell |
456,441
-9,130
| -2% | -$257K | ﹤0.01% | 1867 |
|
|
2013
Q2 | $10.9M | Buy |
+465,571
| New | +$8.37M | ﹤0.01% | 1855 |
|
Other funds holding LGND
JT
CAM
Northern Trust's LGND Position: Q2 2026 in Review
Northern Trust increased its Ligand Pharmaceuticals (LGND) stake by 1.3% in Q2 2026, buying an estimated $761K and bringing the position to 257,389 shares worth $81.4M. The position accounts for 0.01% of the portfolio, ranked #915.
Northern Trust first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $86M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Northern Trust held 257,389 shares of Ligand Pharmaceuticals worth $81.4M as of Q2 2026.
- Northern Trust bought 3,231 Ligand Pharmaceuticals shares in Q2 2026, an estimated $761K.
- Ligand Pharmaceuticals made up 0.01% of Northern Trust's portfolio in Q2 2026, its #915 holding.
- Northern Trust first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Northern Trust's Ligand Pharmaceuticals position peaked at $86M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.